Several new blood-based biomarkers, including des-gamma-carboxy prothrombin, lens culinaris agglutinin-reactive AFP, plasma microRNA expression, methylated DNA markers, circulating tumor DNA, and circulating tumor cells, have been studied [7–12]. This evidence concerns the gene AFP and neoplasm.